http://d.yimg.com/a/p/ap/20100713/ca...H9yZ2YNJBRIA--AP - GlaxoSmithKline's drug Avandia should stay on the market, federal health experts voted Wednesday, but the controversial diabetes pill should be subject to new restrictions due to risky heart side effects.
Source
